Effects of surface modification on delivery efficiency of biodegradable nanoparticles across the blood––brain barrier

Author： Kulkarni Sneha Avinash   Feng Si-Shen  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.6, Iss.2, 2011-02, pp. : 377-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood––brain barrier

By Tosi Giovanni   Fano Rita Adriana   Bondioli Lucia   Badiali Luca   Benassi Rois   Rivasi Francesco   Ruozi Barbara   Forni Flavio   Vandelli Maria Angela  

Nanomedicine, Vol. 6, Iss. 3, 2011-04 ,pp. : 423-436

Future Medicine

Access to resources Recommend Favorite

Brain targeting PBCA nanoparticles and the blood––brain barrier

By Wilson B  

Nanomedicine, Vol. 4, Iss. 5, 2009-07 ,pp. : 499-502

Future Medicine

Access to resources Recommend Favorite

Cell surface levels of endothelial ICAM‐1 influence the transcellular or paracellular T‐cell diapedesis across the blood–brain barrier

By  

EUROPEAN JOURNAL OF IMMUNOLOGY, Vol. 45, Iss. 4, 2015-04 ,pp. : 1043-1058

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted delivery of protein and gene medicines through the blood–brain barrier

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 347-361

John Wiley & Sons Inc

Access to resources Recommend Favorite

Blood–brain barrier: An impediment to neuropharmaceuticals

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 4, 2015-04 ,pp. : 308-313

John Wiley & Sons Inc

Access to resources Recommend Favorite